   <title>These highlights do not include all the information needed to use ADCETRIS safely and effectively. See full prescribing information for ADCETRIS.<br/>ADCETRIS<sup>Â®</sup> (brentuximab vedotin) for Injection<br/>
               <title>WARNING: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)</title>
               <title>1 INDICATIONS AND USAGE</title>
                     <title>1.1 Hodgkin Lymphoma</title>
                     <title>1.2 Systemic Anaplastic Large Cell Lymphoma</title>
               <title>2 DOSAGE AND ADMINISTRATION</title>
                     <title>2.1 General Dosing Information</title>
                     <title>2.2 Dose Modification</title>
                     <title>2.3 Instructions for Preparation and Administration</title>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <title>4 CONTRAINDICATIONS</title>
               <title>5 WARNINGS AND PRECAUTIONS</title>
                     <title>5.1 Peripheral Neuropathy</title>
                     <title>5.2 Infusion Reactions</title>
                     <title>5.3 Neutropenia</title>
                     <title>5.4 Tumor Lysis Syndrome</title>
                     <title>5.5 Progressive Multifocal Leukoencephalopathy</title>
                     <title>5.6 Stevens-Johnson Syndrome</title>
                     <title>5.7 Embryo-Fetal Toxicity</title>
               <title>6 ADVERSE REACTIONS</title>
                     <title>6.1 Clinical Trial Experience</title>
                     <title>6.2 Post Marketing Experience</title>
                     <title>6.3 Immunogenicity</title>
               <title>7 DRUG INTERACTIONS</title>
                     <title>7.1 Effect of Other Drugs on ADCETRIS</title>
                     <title>7.2 Effect of ADCETRIS on Other Drugs</title>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
                     <title>8.1 Pregnancy</title>
                     <title>8.3 Nursing Mothers</title>
                     <title>8.4 Pediatric Use</title>
                     <title>8.5 Geriatric Use</title>
                     <title>8.6 Renal Impairment</title>
                     <title>8.7 Hepatic Impairment</title>
               <title>10 OVERDOSAGE</title>
               <title>11 DESCRIPTION</title>
               <title>12 CLINICAL PHARMACOLOGY</title>
                     <title>12.1 Mechanism of Action</title>
                     <title>12.2 Pharmacodynamics</title>
                     <title>12.3 Pharmacokinetics</title>
               <title>13 NONCLINICAL TOXICOLOGY</title>
                     <title>13.1 Carcinogenesis, Mutagenesis, and Impairment of Fertility</title>
               <title>14 CLINICAL STUDIES</title>
                     <title>14.1 Hodgkin Lymphoma</title>
                     <title>14.2 Systemic Anaplastic Large Cell Lymphoma</title>
               <title>15 REFERENCES</title>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING</title>
                     <title>16.1 How Supplied</title>
                     <title>16.2 Storage</title>
                     <title>16.3 Special Handling</title>
               <title>17 PATIENT COUNSELING INFORMATION</title>
               <title>PACKAGE LABEL</title>
